ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,206,000 | +111.1% | 50,544 | -11.8% | 0.16% | +83.7% |
Q2 2019 | $1,519,000 | +32.0% | 57,325 | -8.6% | 0.09% | +24.6% |
Q1 2019 | $1,151,000 | +21.7% | 62,725 | -17.6% | 0.07% | +13.1% |
Q4 2018 | $946,000 | -60.5% | 76,159 | -56.8% | 0.06% | -37.1% |
Q2 2018 | $2,395,000 | +230.8% | 176,170 | +75.3% | 0.10% | +234.5% |
Q1 2018 | $724,000 | -3.2% | 100,470 | -50.6% | 0.03% | -12.1% |
Q4 2017 | $748,000 | -25.6% | 203,270 | -12.6% | 0.03% | -35.3% |
Q3 2017 | $1,006,000 | +137.3% | 232,470 | +1.3% | 0.05% | +155.0% |
Q1 2017 | $424,000 | +45.2% | 229,590 | +317.9% | 0.02% | +33.3% |
Q2 2016 | $292,000 | – | 54,943 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |